Astrazeneca PLC (AZN)

Key Insights

• SVP and Group Controller Mani Sharma acquired approximately 1 ordinary share across two transactions in April-May 2026, indicating modest insider investment in company stock through the Share Incentive Plan rather than open market purchases.
• Both share acquisitions were made at favorable valuations relative to filing date (April at $196.03 and May at $186.28), suggesting the officer is participating in incentive-based compensation rather than making discretionary market bets.
• The cumulative beneficial ownership position of 31,155 shares represents a routine executive compensation arrangement typical for senior finance leadership, with no unusual concentration or timing patterns that would signal material non-public information.
• All transactions were executed pursuant to the company's formal Share Incentive Plan with appropriate currency conversions documented, indicating proper governance and compliance with insider trading regulations.